The evolution of microglia replacement: A new paradigm for CNS disease therapy
Cell Stem Cell · 2025-12 · 32 (12) · 1807-1832
DOI: 10.1016/j.stem.2025.10.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Stem Cell, 2025-12. Verfasst von Yanxia Rao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Zhongshan Hospital, Laboratory Animal Center, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain S…. Hauptthemen laut MEDLINE: Microglia, Central Nervous System Diseases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 292 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Changping Laboratory, Shanghai Key Basic Research Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Microglia are indispensable for the central nervous system (CNS) development and homeostasis, and mutations in microglia can cause microgliopathies. Correcting these mutations holds therapeutic potential, but conventional gene therapies cannot yet achieve the CNS-wide delivery required for meaningful treatment. Microglia replacement has emerged as a groundbreaking paradigm that removes pathogenic microglia and introduces healthy donor cells. Over the past 5 years (2020-2025), the field has advanced rapidly from first achieving efficient replacement in animals to first-in-human clinical interventions. Here, we summarize microgliopathies as therapeutic targets and trace the historical and technical evolution from the pre-replacement era of low-engraftment approaches to efficient strategies enabling widespread replacement. We outline the mechanistic principles and current methods that underpin efficient replacement. We highlight therapeutic applications ranging from gene correction to engineered "Trojan horse" microglia and explore potential ability enhancement. Finally, we discuss the potential risks and future directions for safe, scalable, and ethically governed clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Zhongshan Hospital, Laboratory Animal Center, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200032, China.
- National Children's Medical Center, Children's Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, MOE Innovative Center for New Dr…
Förderung
- Changping Laboratory
- Shanghai Key Basic Research Program
- National Natural Science Foundation of China
- MOST
Zitieren
APA
Rao, Y., Bai, Y., Li, X., Du, B., & Peng, B. (2025). The evolution of microglia replacement: A new paradigm for CNS disease therapy. Cell Stem Cell, 32(12), 1807-1832. https://doi.org/10.1016/j.stem.2025.10.014
Vancouver
Rao Y, Bai Y, Li X, Du B, Peng B. The evolution of microglia replacement: A new paradigm for CNS disease therapy. Cell Stem Cell. 2025;32(12):1807-1832. doi:10.1016/j.stem.2025.10.014
BibTeX
@article{Rao2025,
author = {Rao, Yanxia and Bai, Yunshang and Li, Xiaoyu and Du, Bingying and Peng, Bo},
title = {The evolution of microglia replacement: A new paradigm for CNS disease therapy},
journal = {Cell Stem Cell},
year = {2025},
volume = {32},
number = {12},
pages = {1807--1832},
doi = {10.1016/j.stem.2025.10.014}
}
EUVIMED